CD73 Pathway Contributes to the Immunosuppressive Ability of Mesenchymal Stem Cells in Intraocular Autoimmune Responses

Stem Cells and Development

Volumn 25, Issue 4, 2016, Pages 337-346

  Chen, Xiteng ^a   Shao, Hui ^b   Zhi, Yuntao ^a   Xiao, Qing ^a   Su, Chang ^a   Dong, Lijie ^a   Liu, Xun ^a   Li, Xiaorong ^a   Zhang, Xiaomin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ATAXIN 1; BETA1 INTEGRIN; CD11B ANTIGEN; CD34 ANTIGEN; CD39 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE UVEITIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPHENOTYPING; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOSYNTHESIS; C57BL MOUSE; CELL PROLIFERATION; ELECTRORETINOGRAPHY; EYE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RETINA; SIGNAL TRANSDUCTION; UVEITIS;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; ELECTRORETINOGRAPHY; EYE; FEMALE; HUMANS; IMMUNOSUPPRESSION; MALE; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; RETINA; SIGNAL TRANSDUCTION; UP-REGULATION; UVEITIS;

EID: 84958160890     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2015.0227     Document Type: Article

References (39)

1. Parekkadan B, AW Tilles and ML Yarmush. (2008). Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 26:1913-1919.
2. Le Blanc K and O Ringden. (2007). Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262:509-525.
3. Casiraghi F, N Azzollini, P Cassis, B Imberti, M Morigi, D Cugini, RA Cavinato, M Todeschini, S Solini, et al. (2008). Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 181:3933-3946.
4. Rasmusson I, O Ringden, B Sundberg and K Le Blanc. (2005). Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 305:33-41.
5. Caplan AI. (2009). Why are MSCs therapeutic? New data: new insight. J Pathol 217:318-324.
6. Ge W, J Jiang, J Arp, W Liu, B Garcia and H Wang. (2010). Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation 90:1312-1320.
7. Shi Y, J Su, AI Roberts, P Shou, AB Rabson and G Ren. (2012). How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 33:136-143.
8. Yu B, X Zhang and X Li. (2014). Exosomes derived from mesenchymal stem cells. Int J Mol Sci 15:4142-4157.
9. Antonioli L, P Pacher, ES Vizi and G Hasko. (2013). CD39 and CD73 in immunity and inflammation. Trends Mol Med 19:355-367.
10. Regateiro FS, SP Cobbold and H Waldmann. (2013). CD73 and adenosine generation in the creation of regulatory microenvironments. Clin Exp Immunol 171:1-7.
11. Sitkovsky MV, D Lukashev, S Apasov, H Kojima, M Koshiba, C Caldwell, A Ohta and M Thiel. (2004). Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22:657-682.
12. Sattler C, M Steinsdoerfer, M Offers, E Fischer, R Schierl, K Heseler, W Daubener and J Seissler. (2011). Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation. Cell Transplant 20:1221-1230.
13. Lee JJ, HJ Jeong, MK Kim, WR Wee, WW Lee, SU Kim, C Sung and YH Yang. (2014). CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function. Purinergic Signal 10:357-365.
14. Chen M, W Su, X Lin, Z Guo, J Wang, Q Zhang, D Brand, B Ryffel, J Huang, et al. (2013). Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation. Arthritis Rheum 65:1181-1193.
15. Shao H, T Liao, Y Ke, H Shi, HJ Kaplan and D Sun. (2006). Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp Eye Res 82:323-331.
16. Caspi RR. (2003). Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol 15:15-16.
17. Zhang X, X Ren, G Li, C Jiao, L Zhang, S Zhao, J Wang, ZC Han and X Li. (2011). Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity. Invest Ophthalmol Vis Sci 52:3143-3152.
18. Zhang L, H Zheng, H Shao, H Nian, Y Zhang, L Bai, C Su, X Liu, LJ Dong, X Li and X Zhang. (2014). Long-term therapeutic effects of mesenchymal stem cells compared with dexamethasone on recurrent experimental autoimmune uveitis of rats. Invest Ophthalmol Vis Sci 55:5561-5571.
19. Li G, L Yuan, X Ren, H Nian, L Zhang, ZC Han, X Li and X Zhang. (2013). The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis. Clin Exp Immunol 173:28-37.
20. Resta R, Y Yamashita and LF Thompson. (1998). Ectoenzyme and signaling functions of lymphocyte CD73. Immunol Rev 161:95-109.
21. Deaglio S, KM Dwyer, W Gao, D Friedman, A Usheva, A Erat, JF Chen, K Enjyoji, J Linden, et al. (2007). Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204:1257-1265.
22. Ernst PB, JC Garrison and LF Thompson. (2010). Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J Immunol 185:1993-1998.
23. Borsellino G, M Kleinewietfeld, D Di Mitri, A Sternjak, A Diamantini, R Giometto, S Hopner, D Centonze, G Bernardi, et al. (2007). Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110:1225-1232.
24. Chalmin F, G Mignot, M Bruchard, A Chevriaux, F Vegran, A Hichami, S Ladoire, V Derangere, J Vincent, et al. (2012). Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity 36:362-373.
25. Zanin RF, E Braganhol, LS Bergamin, LF Campesato, AZ Filho, JC Moreira, FB Morrone, J Sevigny, MR Schetinger, WA de Souza and AM Battastini. (2012). Differential macrophage activation alters the expression profile of NTPDase and ecto-5'-nucleotidase. PLoS One 7:e31205.
26. Csoka B, Z Selmeczy, B Koscso, ZH Nemeth, P Pacher, PJ Murray, D Kepka-Lenhart, SJ Morris, WC Gause, SJ Leibovich and G Hasko. (2012). Adenosine promotes alternative macrophage activation via A2A and A2B receptors. Faseb J 26:376-386.
27. Mizumoto N, T Kumamoto, SC Robson, J Sevigny, H Matsue, K Enjyoji and A Takashima. (2002). CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8:358-365.
28. Chatterjee D, DM Tufa, H Baehre, R Hass, RE Schmidt and R Jacobs. (2014). Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells. Blood 123:594-595.
29. Kukulski F, F Bahrami, YF Ben, J Lecka, M Martin-Satue, SA Levesque and J Sevigny. (2011). NTPDase1 controls IL-8 production by human neutrophils. J Immunol 187:644-653.
30. Corriden R, Y Chen, Y Inoue, G Beldi, SC Robson, PA Insel and WG Junger. (2008). Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. J Biol Chem 283:28480-28486.
31. Algars A, M Karikoski, GG Yegutkin, P Stoitzner, J Niemela, M Salmi and S Jalkanen. (2011). Different role of CD73 in leukocyte trafficking via blood and lymph vessels. Blood 117:4387-4393.
32. Takedachi M, D Qu, Y Ebisuno, H Oohara, ML Joachims, ST McGee, E Maeda, RP McEver, T Tanaka, et al. (2008). CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes. J Immunol 180:6288-6296.
33. Romio M, B Reinbeck, S Bongardt, S Huls, S Burghoff and J Schrader. (2011). Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. Am J Physiol Cell Physiol 301:C530-C539.
34. Smyth LA, K Ratnasothy, JY Tsang, D Boardman, A Warley, R Lechler and G Lombardi. (2013). CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function. Eur J Immunol 43:2430-2440.
35. Regateiro FS, D Howie, KF Nolan, EI Agorogiannis, DR Greaves, SP Cobbold and H Waldmann. (2011). Generation of anti-inflammatory adenosine by leukocytes is regulated by TGF-beta. Eur J Immunol 41:2955-2965.
36. Dwyer KM, S Deaglio, W Gao, D Friedman, TB Strom and SC Robson. (2007). CD39 and control of cellular immune responses. Purinergic Signal 3:171-180.
37. Ohta A, A Ohta, M Madasu, R Kini, M Subramanian, N Goel and M Sitkovsky. (2009). A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments. J Immunol 183:5487-5493.
38. Lappas CM, JM Rieger and J Linden. (2005). A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol 174:1073-1080.
39. Naganuma M, EB Wiznerowicz, CM Lappas, J Linden, MT Worthington and PB Ernst. (2006). Cutting edge: critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol 177:2765-2769.